Quick Answer
PRECIGEN, INC. reported R&D Expense of $41.33 million for fiscal year 2025.
PRECIGEN, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $41.33M | -22.1% |
| 2024 | $53.07M | +9.2% |
| 2023 | $48.61M | -88.0% |
| 2018 | $404.59M | +182.5% |
| 2017 | $143.21M | +27.7% |
| 2016 | $112.14M | -24.0% |
| 2015 | $147.48M | +150.0% |
| 2014 | $58.98M | +22.5% |
| 2013 | $48.14M | -24.8% |
| 2012 | $64.03M | -8.8% |
| 2011 | $70.23M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2019 | $31.48M | -29.9% | -8.8% |
| June 30, 2019 | $34.52M | -17.9% | +4.4% |
| March 31, 2019 | $33.06M | -11.3% | -26.3% |
| September 30, 2018 | $44.88M | +23.1% | +6.7% |
| June 30, 2018 | $42.05M | +23.6% | +12.8% |
| March 31, 2018 | $37.27M | +9.0% | +2.2% |
| September 30, 2017 | $36.47M | +25.6% | +7.2% |
| June 30, 2017 | $34.01M | +19.9% | -0.5% |
- PRECIGEN, INC. showed a decrease of -22.1% in R&D Expense compared to the prior fiscal year.
- Over the 2011–2025 period, PRECIGEN, INC.’s r&d expense has declined by 41.1% (from $70.23 million to $41.33 million).
- The most recent figure is from PRECIGEN, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: